EW vs HURA · P/E 47, rev $3.39B vs $125.1M cap
Edwards Lifesciences Corp (EW) versus TuHURA Biosciences Inc (HURA) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
TuHURA Biosciences Inc (HURA) is a biotechnology company listed on US.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported HURA revenue for 2026-03-31 was $0. Net income was -$7.5M. HURA currently screens at market cap $125.1M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. HURA currently screens at market cap $125.1M.
Not investment advice. Open the EW and HURA stock pages for the full models.
Not investment advice.